Gemcitabine/5-flourouracil/leucovorin for the treatment of advanced pancreatic carcinoma

Gemcitabine/5-flourouracil/leucovorin for the treatment of advanced pancreatic carcinoma

BACKGROUND AND OBJECTIVE: The response rate and median survival with gemcitabine monotherapy, although considered the standard treatment for inoperable and metastatic pancreatic cancer, is relatively poor. We tested the efficacy and toxicity of a chemotherapy protocol consisting of gemcitabine, 5-fl...

Full description

Bibliographic Details
Main Authors:	Reza Malayeri, Mehrdad Ghassemboland, Faraz Ranjpoor, Abdolreza Maadi
Format:	Article
Language:	English
Published:	Elsevier 2008-10-01
Series:	Hematology/Oncology and Stem Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S1658387608500082

Similar Items

Comparative efficacy of 5flourouracil/calcium leucovorine versus 5flourouracil/calcium leucovorine plus oxaliplatin in the adjuvant treatment of colonic carcinoma in Kashmir
by: Hamid Deva Shaiq, et al.
Published: (2013-01-01)

Mature Results of a Prospective Randomized Trial Comparing 5-Flourouracil with Leucovorin to 5-Flourouracil with Levamisole as Adjuvant Therapy of Stage II and III Colorectal Cancer- The Israel Cooperative Oncology Group (ICOG) Study
by: Arie Figer, Aviram Nissan, Adi Shani, Riva Borovick, Mariana Stiener, Mario Baras, Herbert R. Freund, Aaron Sulkes, Alexander Stojadinovic, Tamar Peretz
Published: (2011-01-01)

Treatment of Gemcitabine and 5-Fluorouracil/Leucovorin in Advanced Non-Small Cell Lung Cancer: A phase II pilot study
by: Che-Ling Lin, et al.
Published: (1999)

Resveratrol abrogates 5-flourouracil -induced hepatotoxicity: A preclinical study
by: Elias Adikwu, et al.
Published: (2020-12-01)

Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan.
by: Chia-Yu Chen, et al.
Published: (2020-01-01)

Effect of 5-Flourouracil On HCT-116 P53+/- Human Colon Cancer Cells
by: Perwaiz, Sunela
Published: (2011)

Evaluation of Low Molecular Weight Cross Linked Chitosan Nanoparticles, to Enhance the Bioavailability of 5-Flourouracil
by: Aisha Sethi, et al.
Published: (2021-07-01)

Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard Therapies
by: Seiichiro Mitani, et al.
Published: (2019-04-01)

Low-cost outpatient chemotherapy regimen of cisplatin, 5-fluorouracil and leucovorin for advanced head and neck and esophageal carcinomas
by: Vanessa de Carvalho Fabrício, et al.

Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma
by: Run-Bin Liang, et al.
Published: (2021-05-01)

BEVACIZUMAB COMBINED WITH IRINOTECAN, 5-FLUOROURACIL AND LEUCOVORIN AS THE FIRST- LINE TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA
by: Deyan Davidov
Published: (2014-12-01)

OXALIPLATIN/5-FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan N. Davidov
Published: (2013-12-01)

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
by: Habermehl Daniel, et al.
Published: (2012-03-01)

Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx
by: Hung-Ming Wang, et al.
Published: (2014-06-01)

Interdependence of Gemcitabine Treatment, Transporter Expression, and Resistance in Human Pancreatic Carcinoma Cells
by: Wolfgang Hagmann, et al.
Published: (2010-09-01)

Clinical Study of Combining Chemotherapy of Oxaliplatin or 5-Fluorouracil/Leucovorin with Hydroxycamptothecine for Advanced Colorectal Cancer
by: Yuanjue SUN, et al.
Published: (2009-04-01)

Role of Maintenance Gemcitabine in Advanced Carcinoma Gallbladder
by: Manish Sharma, et al.
Published: (2020-10-01)

Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma.
by: Katarzyna A Ellsworth, et al.
Published: (2013-01-01)

Role of ABCC5 in Gemcitabine Resistance in Pancreatic Cancer
by: Bugde, Piyush
Published: (2019)

Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma
by: Gong DJ, et al.
Published: (2013-07-01)

Preoperative chemoradiation in locally advanced rectal cancer: A comparison of bolus 5-fluorouracil/leucovorin and capecitabine
by: Adnan Yoney, et al.
Published: (2014-01-01)

A Case of Metastatic Urachal Carcinoma Treated With FOLFIRI (irinotecan and 5-Fluorouracil/leucovorin) Plus Bevacizumab
by: Tomohiro Kanamaru, et al.
Published: (2015-03-01)

Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
by: Neoptolemos John P, et al.
Published: (2008-07-01)

Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma
by: Yuan Zhang, et al.
Published: (2019-06-01)

Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
by: L. Perkhofer, et al.
Published: (2019-10-01)

FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancer.
by: Junmei Hou, et al.
Published: (2012-01-01)

Pancreatic Cancer Chemoresistance to Gemcitabine
by: Manoj Amrutkar, et al.
Published: (2017-11-01)

Low-dose versus Standard-Dose Leucovorin in the Treatment of Colon Cancer: Mansoura University Clinical Experience in Facing the Problem of Leucovorin Shortage
by: Hend Elkalla, et al.
Published: (2019-06-01)

Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study
by: Jung Hoon Kim, et al.
Published: (2018-06-01)

The Compatibility of Fluorouracil with Leucovorin on Particulate Evaluation
by: Chia-Ling Kuo, et al.
Published: (2005)

Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
by: Jane E. Rogers, et al.
Published: (2020-08-01)

Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer.
by: Gustav J Ullenhag, et al.
Published: (2017-01-01)

Gemcitabine and cisplatin regimen facilitates prognosis of advanced nasopharyngeal carcinoma
by: Qiongxuan Li, et al.
Published: (2018-07-01)

High-intensity focused ultrasound therapy in combination with gemcitabine for unresectable pancreatic carcinoma
by: Lv W, et al.
Published: (2016-05-01)

Harmine suppresses the proliferation of pancreatic cancer cells and sensitizes pancreatic cancer to gemcitabine treatment
by: Wu LW, et al.
Published: (2019-06-01)

Mechanisms of gemcitabine resistance in pancreatic cancer
by: Melling, J.
Published: (2017)

Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers
by: Anant Ramaswamy, et al.
Published: (2018-01-01)

A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial
by: Francesca Simionato, et al.
Published: (2020-09-01)

Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer
by: Li-Tzong Chen, et al.
Published: (2019-07-01)

Safety Study of Targeted and Localized Intra-Arterial Delivery of Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma
by: Alexander S. Rosemurgy, et al.
Published: (2017-08-01)

Cannot write session to /tmp/vufind_sessions/sess_a4k33i3209c8gtic793rmgbmo0